Veterinary medicines European public assessment report (EPAR): Bluevac-3, bluetongue virus vaccine (inactivated), Status: Authorised
Union product database: webinar for veterinary marketing authorisation holders on an industry dedicated read API, Online, from 27 February 2025, 11:00 (CET) to 27 February 2025, 12:00 (CET)
Annex to 24-27 February 2025 CHMP Agenda
Frequently asked questions (FAQs) : How to create and submit an annual safety report and respond to related requests for information - CTIS Training Programme - Module 18
Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Minutes - PDCO minutes of the 12-15 November 2024 meeting
Vitrolife IVF media - Procedural steps and scientific information after initial consultation
Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): ReFacto AF, moroctocog alfa, Date of authorisation: 13/04/1999, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised